Antitumor activity of Z15-0-2, a bispecific nanobody targeting PD-1 and CTLA-4
Sign Up to like & getrecommendations! Published in 2024 at "Oncogene"
DOI: 10.1038/s41388-024-03066-5
Abstract: The combination of programmed cell death protein 1 (PD-1) and cytotoxic T lymphocyte antigen 4 (CTLA-4) antibodies has potential for enhancing clinical efficacy. We described the development and antitumor activity of Z15-0, a bispecific nanobody… read more here.
Keywords: antitumor activity; z15; bispecific nanobody; activity z15 ... See more keywords